Skip to main content
. 2011 Oct 27;6(10):e26276. doi: 10.1371/journal.pone.0026276

Figure 2. DST patterns in patients with no reported risk factors for MDR-TB: rates and confidence intervals.

Figure 2

Legend: Mono resistant: resistance to a single drug out of the four tested; Poly resistant: resistance to at least two drugs not involving the combination of isoniazid and rifampicin; Only MDR: resistance to isoniazid and rifampicin only; MDR plus: resistance to isoniazid, rifampicin and another drug.